Biosimilar Rutiximabs, and Inotuzumab, Coming to Europe - Medscape

Medscape
Biosimilar Rutiximabs, and Inotuzumab, Coming to Europe
Medscape
Two biosimilar versions of the monoclonal antibody rituximab have been recommended for approval in Europe, having been found to be "highly similar" to the reference product, rituximab (MabThera, Roche). The two new biosimilars are Rixathon and ...